BGT 2.33% 4.4¢ bio-gene technology ltd

Ann: Improved Manufacturing Process for Flavocide, page-22

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,880 Posts.
    lightbulb Created with Sketch. 294

    Hi @RNClarke
    Been watching this one since IPO, I did get a few on the day...doesn’t look like it’s getting any cheaper yet the de-risk keeps growing, go figure...now moving toward pilot plant production, giddy up!

    Jumping onboard ASAP...as soon as my other holds recover a little from the beating today..

    Richard Jagger, Bio-Gene CEO commented: “Achieving a commercially viable manufacturing process of our compound is an important milestone not only for Bio-Gene but also for prospective partners. These improvements in the manufacturing process underpin the long term supply of our product. We are now in a position to engage targeted manufacturers to undertake pilot plant production of Flavocide.”


    GLTA.
    Last edited by Tech goose: 11/10/18
 
watchlist Created with Sketch. Add BGT (ASX) to my watchlist
(20min delay)
Last
4.4¢
Change
0.001(2.33%)
Mkt cap ! $8.859M
Open High Low Value Volume
4.4¢ 4.4¢ 4.4¢ $5 112

Buyers (Bids)

No. Vol. Price($)
1 20000 4.2¢
 

Sellers (Offers)

Price($) Vol. No.
4.5¢ 12375 1
View Market Depth
Last trade - 10.00am 29/11/2024 (20 minute delay) ?
BGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.